X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (57) 57
ophthalmology (51) 51
index medicus (49) 49
female (44) 44
male (44) 44
article (36) 36
macular degeneration (31) 31
aged (29) 29
clinical trials (28) 28
middle aged (26) 26
visual acuity - physiology (24) 24
fluorescein angiography (23) 23
physiological aspects (23) 23
angiogenesis inhibitors - therapeutic use (22) 22
comparative analysis (22) 22
aged, 80 and over (21) 21
ranibizumab (20) 20
drug therapy (19) 19
vascular endothelial growth factor a - antagonists & inhibitors (19) 19
tomography, optical coherence (18) 18
bevacizumab (17) 17
prospective studies (17) 17
risk factors (17) 17
cohort studies (16) 16
antibodies, monoclonal, humanized - therapeutic use (15) 15
intravitreal injections (15) 15
wet macular degeneration - drug therapy (15) 15
incidence (11) 11
prevalence (11) 11
child, preschool (10) 10
children (10) 10
cross-sectional studies (10) 10
follow-up studies (10) 10
wet macular degeneration - diagnosis (10) 10
risk-factors (9) 9
treatment outcome (9) 9
visual acuity (9) 9
care and treatment (8) 8
macular degeneration - drug therapy (8) 8
progression (8) 8
wet macular degeneration - physiopathology (8) 8
amblyopia (6) 6
analysis (6) 6
bevacizumab - therapeutic use (6) 6
diabetes (6) 6
medical colleges (6) 6
neovascularization (6) 6
optical coherence tomography (6) 6
ranibizumab - therapeutic use (6) 6
risk (6) 6
abridged index medicus (5) 5
adult (5) 5
angiogenesis inhibitors - administration & dosage (5) 5
choroidal neovascularization - diagnosis (5) 5
choroidal neovascularization - drug therapy (5) 5
endothelial growth factors (5) 5
macular degeneration - complications (5) 5
macular degeneration - diagnosis (5) 5
obesity - complications (5) 5
obesity - therapy (5) 5
photography (5) 5
retina - pathology (5) 5
united states - epidemiology (5) 5
visual-acuity (5) 5
age related macular degeneration (4) 4
antibodies, monoclonal, humanized - administration & dosage (4) 4
association (4) 4
astigmatism (4) 4
child (4) 4
complications and side effects (4) 4
diabetes mellitus, type 2 - complications (4) 4
disease (4) 4
endothelial growth-factor (4) 4
eye (4) 4
genotype (4) 4
geographic atrophy - diagnosis (4) 4
geographic atrophy - epidemiology (4) 4
laser coagulation (4) 4
maculopathy (4) 4
medical research (4) 4
medicine, experimental (4) 4
natural-history (4) 4
odds ratio (4) 4
pediatric-eye-disease (4) 4
pediatrics (4) 4
polymorphism, single nucleotide (4) 4
prevention (4) 4
reproducibility of results (4) 4
retinopathy (4) 4
retinoscopy (4) 4
screening-tests (4) 4
subretinal fluid (4) 4
surveys and questionnaires (4) 4
susceptibility (4) 4
vascular endothelial growth factor (4) 4
wet macular degeneration - genetics (4) 4
angiogenesis inhibitors (3) 3
associations (3) 3
cardiovascular disease (3) 3
choroidal neovascularization - physiopathology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 1, pp. 150 - 161
Journal Article
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 7, pp. 1388 - 1398
Objective To describe effects of ranibizumab and bevacizumab when administered monthly or as needed for 2 years and to describe the impact of switching to... 
Ophthalmology | OPHTHALMOLOGY | Macular degeneration | Care and treatment | Angiogenesis inhibitors | Drug therapy | Analysis
Journal Article
Ophthalmology, ISSN 0161-6420, 2016, Volume 124, Issue 3, pp. e33 - e33
Journal Article
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 3, pp. 656 - 666
Journal Article
Ophthalmology, ISSN 0161-6420, 2013, Volume 120, Issue 3, pp. 593 - 599
Journal Article
Journal Article
Ophthalmology, ISSN 0161-6420, 2015, Volume 122, Issue 4, pp. 809 - 816
Journal Article